SpecklesS
commented on
$Sangamo Therapeutics (SGMO.US)$ Do you think it will still be up tomorrow?
1
SpecklesS
voted
Morning traders, Happy Monday. The market is open and moving somewhat slowly, but my name is Kevin Travers, and here are your morning moving stocks and stories from the herd on Wall St. today.
$McDonald's (MCD.US)$ reported a triple miss with second-quarter results Monday, as profit and revenue fell below expectations. Comparable sales fell, despite higher prices, and not enough customers journeyed to the gold...
$McDonald's (MCD.US)$ reported a triple miss with second-quarter results Monday, as profit and revenue fell below expectations. Comparable sales fell, despite higher prices, and not enough customers journeyed to the gold...
![Market Settles after Pullback Week, Investors Await Earnings and FOMC | Herd on Wall St.](http://1500015405.vod2.myqcloud.com/57f4fa2avodtransusw1500015405/d12599a11253642700785853145/coverBySnapshot/coverBySnapshot_10_0.jpg)
41
7
SpecklesS
voted
$CrowdStrike (CRWD.US)$
Investors are selling their shares and switching to other cybersecurity stocks.
Let's look at other major outages in history and the impact on the stock prices.
$Meta Platforms (META.US)$ On October 4, 2021, a configuration error in Facebook's backbone routers caused a global outage of Facebook, Instagram, WhatsApp, and Messenger for nearly six hours, affecting billions of users.
Stock price effect: -4.9% 📉
Stock price the...
Let's look at other major outages in history and the impact on the stock prices.
$Meta Platforms (META.US)$ On October 4, 2021, a configuration error in Facebook's backbone routers caused a global outage of Facebook, Instagram, WhatsApp, and Messenger for nearly six hours, affecting billions of users.
Stock price effect: -4.9% 📉
Stock price the...
![Friday's IT outage marks the end of Crowdstrike.?](https://ussnsimg.moomoo.com/sns_client_feed/70042948/20240723/67dbfcf7cf274766aea896d239bd89aa.png/thumb?area=100&is_public=true)
![Friday's IT outage marks the end of Crowdstrike.?](https://ussnsimg.moomoo.com/sns_client_feed/70042948/20240723/762fe53110d1428bb5046d065e7a4f89.png/thumb?area=100&is_public=true)
![Friday's IT outage marks the end of Crowdstrike.?](https://ussnsimg.moomoo.com/sns_client_feed/70042948/20240723/5dae10622b754a5e861e4b882d324095.png/thumb?area=100&is_public=true)
4
3
$Trump Media & Technology (DJT.US)$ that’s huge, God Bless Trump and America 💕
1
$CenterPoint Energy (CNP.US)$ day 4 without power. Thank you for all your hard work and risk management and proactive team. Thank you for actively trimming overgrown trees near power lines, so a two minutes of heavy wind won’t affect our lives and jobs.
1
1
SpecklesS
commented on
$Invesco QQQ Trust (QQQ.US)$ im so tried of being screw in the markets someway or another anytime im happy and killing it some bs like my orders failing and callings them not working till it way to late why so tired of this crappy world why does this always happen when im doing to good I just can't understand how its always at the worst time when I have the most to lose something crazy happens and I get stuck or instantly screwed like it really real sucks I just want a fair chance here like there...
7
SpecklesS
voted
$Tesla (TSLA.US)$ who will reach $200 first?
1
1
SpecklesS
commented on
$Allarity Therapeutics (ALLR.US)$
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
Allarity Therapeutics announced that multiple patients in its Phase 2 trial of stenoparib for advanced ovarian cancer have exceeded 30 weeks of treatment. Stenoparib demonstrated significant tumor shrinkage and long-term disease stability, prompting the company to halt patient enrollment to focus on a follow-on trial aimed a...
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
Allarity Therapeutics announced that multiple patients in its Phase 2 trial of stenoparib for advanced ovarian cancer have exceeded 30 weeks of treatment. Stenoparib demonstrated significant tumor shrinkage and long-term disease stability, prompting the company to halt patient enrollment to focus on a follow-on trial aimed a...
7
2